Table 9.
Multivariate analysis of factors independently associated with recovery of renal function post-OLT stratified according to groups
| Regression coefficient | S.E. | p | OR (95% CI) | Coefficient of variation | |
|---|---|---|---|---|---|
|
SCr ≥2 mg/dL, not requiring dialysis (n = 650) |
|
|
|
|
|
| Allograft dysfunction |
−1.388 |
0.090 |
0.0001 |
0.061 (0.163-0.383) |
0.11 |
|
Dialysis at registration only |
|
|
|
|
|
|
(n = 178) |
|
|
|
|
|
| Allograft dysfunction |
−1.86 |
0.55 |
0.00001 |
0.159 (0.054-0.990) |
0.119 |
| MELD score |
−0.019 |
0.021 |
0.016 |
0.95 (0.91-0.99) |
0.058 |
|
Dialysis at transplant only |
|
|
|
|
|
|
(n = 519) |
|
|
|
|
|
| Allograft dysfunction |
−1.42 |
0.26 |
0.00001 |
0.24 (0.14-0.40) |
0.084 |
| Transplanted before MELD |
−0.83 |
0.21 |
0.00001 |
0.43 (0.289-0.670) |
0.033 |
| Anti-thymocyte globulin induction |
1.76 |
0.70 |
0.010 |
4.80 (1.23-19.10) |
0.019 |
| Cyclosporine |
−0.77 |
0.27 |
0.030 |
0.46 (0.27-0.78) |
0.011 |
| Tacrolimus |
−0.5 |
0.23 |
0.029 |
0.40 (0.40-0.95) |
0.011 |
|
Dialysis-dependence |
|
|
|
|
|
|
(n = 373) |
|
|
|
|
|
| Allograft dysfunction |
−1.752 |
0.358 |
0.00001 |
0.173 (0.086-0.350) |
0.139 |
| Donor age |
−0.019 |
0.008 |
0.020 |
0.98 (0.96-1.0) |
0.044 |
| Recipient bilirubin (total) |
−0.025 |
0.009 |
0.004 |
0.97 (0.96-0.99) |
0.040 |
| Donor ALT | 0.008 | 0.003 | 0.020 | 1.008 (1.001-1.015) | 0.028 |
Abbreviations: ALT alanine transaminase, BMI body mass index, CI confidence interval, MELD model end-stage liver disease, OLT orthotopic liver transplantation, OR odds ratio, SCr serum creatinine.